Top 1% Biotech, A Merck Rival, Plummets On A Surprise Failure - Investor's Business Daily

07.06.2025 20:02

Patients treate… [+2487 chars]

Summit Therapeutics (SMMT) stock plunged Friday after its highly-watched cancer drug slowed progression, but failed to significantly improve overall survival in lung cancer patients.

Read also:

The First At-Home Cervical Cancer Screening Device Was Approved by the FDA, Set to Roll Out This Year - Good News Network
Strawberry Moon 2025: June’s full moon to light up the sky this month- know date, time, and the science b - Times of India
How do I find a transgender girlfriend?
Instagram for iPad is reportedly coming soon; here’s when to expect it - 9to5Mac
Treasury Secretary Busts ‘Alarmist’ Inflation Predictions - The Daily Wire
She Never Stopped Hoping Her Cat Had Survived — Then Came A Life-Changing Call - The Dodo - For Animal People
What is the most interesting question you can ask to get to know someone?
How can I move on from my ex?
Is it possible for people who claim to be genuine and honest to actually not be? If so, why do they behave this way?
Why do people who were very kind and loving once become cold-hearted?
Six Types Of Dinosaur Eggs Found In One Place - The Daily Galaxy
The Best Father’s Day Gifts On Amazon That Dads Can Actually Use - HuffPost
Can you explain the concept of an annulment of marriage in the Roman Catholic Church and its effects on a previous marriage?